Abingworth as of March 31, 2022
Portfolio Holdings for Abingworth
Abingworth holds 20 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 28.5 | $101M | 4.2M | 24.11 | |
| Vera Common (VERA) | 19.7 | $69M | 3.0M | 23.41 | |
| Adicet Common (ACET) | 12.0 | $42M | 2.1M | 19.93 | |
| Sierra Oncology Common | 11.9 | $42M | 1.3M | 32.05 | |
| Jasper Common | 5.5 | $20M | 5.6M | 3.47 | |
| Phathom Common (PHAT) | 5.5 | $20M | 1.4M | 13.59 | |
| eFFECTOR Common | 5.4 | $19M | 4.8M | 3.92 | |
| Verona Sponds Adr (VRNA) | 3.4 | $12M | 2.5M | 4.94 | |
| Reneo Common (RPHM) | 1.7 | $6.1M | 2.1M | 2.93 | |
| Sientra Common | 1.5 | $5.2M | 2.3M | 2.21 | |
| Soleno Common | 1.1 | $4.0M | 18M | 0.22 | |
| Spruce Bio Common | 1.0 | $3.6M | 1.8M | 1.99 | |
| Nucana Adr | 0.9 | $3.3M | 3.3M | 0.98 | |
| Paratek Common | 0.9 | $3.1M | 1.0M | 2.96 | |
| Exicure Common | 0.4 | $1.4M | 7.0M | 0.20 | |
| Molecular Templates Common | 0.2 | $690k | 200k | 3.45 | |
| Aeglea Common | 0.2 | $553k | 241k | 2.30 | |
| Cymabay Common | 0.1 | $406k | 131k | 3.10 | |
| Obseva Common | 0.0 | $133k | 88k | 1.51 | |
| Ocugen Common | 0.0 | $23k | 7.1k | 3.23 |
